medigraphic.com
ISSN 2520-9078 (Electronic)

2020, Number 4

<< Back Next >>

Revista de Ciencias Médicas de la Habana 2020; 27 (4)

Utility of the scale for ICTUS risk and anticoagulant treatment in atrial fibrillation

Quintana BA, Díaz LM, Mendieta PMD, López PHG

Language: Spanish
References: 19
Page: 490-499
PDF size: 990.79 Kb.


ABSTRACT

Introduction: The atrial fibrillation is the most frequent cardiac arrhythmia, with prevalence of 1-2 % in the general population. The risk of systemic embolism or the cerebrovascular accidents are among the most feared complications, for that reason different stratification scales of thrombotic risk which allow to predict and guide the preventive therapy with antithrombotic agents.
Objective: To evaluate the utility of the predictive CHAD2DS2-VASc scale of ischemic ICTUS for the application of the treatment with anticoagulant in patient with atrial fibrillation and stroke.
Methods: An observational, longitudinal and prospective study was carried out with 131 admitted patients with non-valvular atrial fibrillation and ischemic Ictus at ¨Aleida Fernández Chardiet¨ Teaching Clinical-Surgical Hospital, between January, 2015 and June, 2017. The variables age, sex, type of atrial fibrillation, level of risk according to the scale to suffer from an ischemic ICTUS and the fulfillment of treatment with oral anticoagulant according to the level of present risk.
Results: The female sex (59.54 %), and the 65 to 74 age group (51.15 %) prevailed, permanent atrial fibrillation with rapid ventricular response (48.09 %), and hypertension also prevailed within the evaluated items by the CHAD2DS2-VASc (72.52 %) and the fulfillment of the treatment with platelet antiagregants (59.54 %) in spite of a predominance of high risk (60.31 %) according to the scale.
Conclusions: The characteristics of the studied population with atrial fibrillation are similar to the ones described in literature, but there is low adherence to therapeutic recommendations with anti-coagulation.


REFERENCES

  1. Pintoa Diego A, Sánchez Vallejo CA, López Pedrazac A, Vergarad Erika P, Sáenza Óscar A, González F, Martínez-Acosta JC, Bonilla P, Remolina S. Descripción de los pacientes con fibrilación auricular no valvular que ingresan al servicio de urgencias. Rev Colomb Cardiol [Internet]. 2016 [citado 2 Mar 2020];23(4):270-6. Disponible en: https://www.sciencedirect.com/science/article/pii/S0120563315001989

  2. Cutiño Maás Y, Rojas Fuentes J, Sánchez Lozano A, López Argüelles J, Verdecia Fraga R, Herrera Alonso D. Characterization of ictus in the long-lived patient: a decade of study. Rev Finlay [Internet]. 2016 Dic [citado 2 Mar 2020];6(3):239-45.Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2221-24342016000300007&lng=es

  3. Jaramillo Jaramillo LI, Marín Castro AE, Velásquez Viveros PA, Ramirez Palacio M, Cañas E. Caracterización de un grupo de pacientes del programa de anticoagulación de una institución de salud y evaluación de los resultados de la escala HAS - BLED y la escala CHA2DS2 – VASc, Medellín (Colombia), 2011-2012. Arch Med (Manizales) [Internet]. 2017 [citado 2 Mar 2020];17(2):303. Disponible en: https://revistasum.umanizales.edu.co/ojs/index.php/archivosmedicina/article/view/1981

  4. Mendieta Pedroso MD, Bender del Busto JE, González López I, Vallejo Ramírez A. Mortalidad por enfermedad cerebrovascular en mayores de 60 años en Mayabeque 2011- 2017. Medimay [Internet]. 2018 [citado 27 Ene 2020];25(2). Disponible en: http://revcmhabana.sld.cu/index.php/rcmh/article/view/1230

  5. Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, et al. Relation of the HAS-BLED bleeding risk score to major bleeding events, and mortality in anticoagulated patients with atrial fibrillation. Circ Arrhythm Electrophysiol [Internet]. 2012 [citado 27 Ene 2020];5(2):312-8. Disponible en: https://www.ahajournals.org/doi/10.1161/CIRCEP.111.967000?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

  6. García Fernandez A, Marín F, Roldán V, Galcerá Jornet E, Martínez Martínez JG, Valdés M, et al. The HAS-BLED score predics long term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion. Int J Cardiol [Internet]. 2016 [citado 27 Ene 2020];217:42-8. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S0167527316308932?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0167527316308932%3Fshowall%3Dtrue&referrer= https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F27179207%2F

  7. Hsieh MJ, Lee CH, Chen CC, Chang SH, Wang CY, Hsieh IC. Predictive performance of HAS-BLED risk score for long term survival in patients with non-ST elevated myocardial infarction without atrial fibrillation. J Cardiol [Internet]. 2017 [citado 27 Ene 2020];69(1):136-43. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0 S0914508716000526?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0914508716000526%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F26951606%2F

  8. Puurunen MK, Kiviniemi T, Schlitt A, Rubboli A, Di¬etrich B, Karjalainen P, et al. CHADS2, CHA2DS2- VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. Throm Res [Internet]. 2014 [citado 27 Ene 2020];133(4):560-6. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S0049384814000310?returnurl= https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0049384814000310%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F24461143%2F

  9. Liu J, Wang D, Tan G, Yuan R, Xu M, Xiong Y, et al. Predicting the outcomes of acute ischemic stroke with rheumatic heart disease: the values of CHADS2, CHA2DS2-VASc and HAS-BLED Scores. J Stroke Cerebrovas Dis [Internet]. 2016 [citado 27 Ene 2020];25(3):722-6. Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S1052305715004899?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1052305715004899%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F26774873%2F

  10. Cruz Cardentey M, Pérez Rivera T, Méndez Rosabal A. Factores predictores de éxito de la cardioversión eléctrica en la fibrilación auricular. Cor Salud [Internet]. 2014 [citado 11 Nov 2019];6:280-7.Disponible en: http://www.corsalud.sld.cu/sumario/2014/v6n4a14/cv-fa.html

  11. Clua-Espuny JL, Lechuga-Duran I, Bosch-Princep R. Prevalencia de la fibrilaciónauricular desconocida y la no tratada con anticoagulantes. Estudio AFABE. Rev Esp Cardiol [Internet]. 2013 [citado 27 Ene 2020];66(7):545-52. Disponible en: https://www.revespcardiol.org/es-prevalencia-fibrilacion-auricular-desconocida-no-articulo-S0300893213001462

  12. Chávez González E, Carmona Puerta R. Razones y método para prevenir la fibrilación auricular cuando puede lograrse. CorSalud [Internet]. 2012 [citado 14 Nov 2019];4:144-5. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/92/238

  13. Rodríguez Rosales E, de Arazoza Hernández A, Vázquez Castro F, Moreno-Martínez FL. Factores de riesgo de fibrilación auricular posoperatoria en cirugía cardíaca. CorSalud [Internet]. 2014 [citado 22 Oct 2019];6:174-80. Disponible en: http://www.corsalud.sld.cu/sumario/2014/v6n2a14/fapo.html

  14. García Acuña JM, González Juanatey JR, Alegría Ezquerra E, González Maqueda I, Listerri JL. La fibrilación auricular permanente en las enfermedades cardiovasculares en España. Estudio CARDIOTENS 1999. Rev Esp Cardiol [Internet]. 2002 [citado 27 Ene 2020];55(9):943-52. Disponible en: https://www.revespcardiol.org/es-pdf-13036120

  15. Merino Barrera Samuel I, Mirella Mercedes J, Landaverde Hernández JR, Lazo Majano SC. et al. Caracterización de la fibrilación auricular en el Servicio de Medicina Interna del Hospital Nacional San Rafael (El Salvador). CorSalud [Internet]. 2016Ene-Mar [citado 27 Ene 2020];8(1):8-18. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/92/238

  16. Del Corral Beamonte E, Fleta Asín B, Martínez Moya L, García Noain A, Gonzalvo Liarte MA. Hipertensión arterial, un antecedente frecuente en los pacientes con fibrilación auricular. Comunicaciones. 9ª Reunión Nacional SEH-LELHA [CD-ROM]. Murcia: Elsevier; 2004.

  17. Komatsu T, Sato Y, Ozawa M, Kunugita F, Yoshizawa R, Morino Y, et al. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification ofischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillationnot receiving anticoagulant therapy. Int Heart J [Internet]. 2014 [citado 27 Ene 2020];55(2):119-25. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709623/pdf/1349-7235-56-2827.pdf

  18. Aguilar Linares G, Valdés Álvarez K, Senra Armas Luis A. Utilización de la anticoagulación en fibrilación auricular no reumática para profilaxis de accidentes cerebrovasculares. Rev Cubana Med [Internet]. 2015 Jun [citado 25 Nov 2020];54(2):129-38. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S003475232015000200004&lng=es. http://scielo.sld.cu/pdf/med/v54n2/med04215.pdf

  19. Marcucci M, Lip GY, Nieuwlaat R, Pisters R, Crijns HJ, Iorio A. Stroke and bleeding risk co-distribution in real-word patients with atrial fibrillation: the Euro Heart Survey. Am J Med [Internet]. 2014 [citado 27 Ene 2020];127(10). https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S0002934314003878?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0002934314003878%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F24838192%2F




2020     |     www.medigraphic.com